GenSight Biologics
(OTC) GSGTF
GenSight Biologics Financials at a Glance
Market Cap
$44.61M
Revenue (TTM)
$1.26M
Net Income (TTM)
$35.23M
EPS (TTM)
$-0.14
P/E Ratio
-1.35
Dividend
$0.00
Beta (Volatility)
-127.38 (Low)
Dividend
$0.00
Beta (Volatility)
-127.38 (Low)
Price
$0.19
Volume
2,000
Open
$0.19
Price
$0.19
Volume
2,000
Open
$0.19
Previous Close
$0.19
Daily Range
$0.19 - $0.19
52-Week Range
$0.19 - $0.24
Dividend
$0.00
Beta (Volatility)
-127.38 (Low)
Price
$0.19
Volume
2,000
Open
$0.19
Previous Close
$0.19
Daily Range
$0.19 - $0.19
52-Week Range
$0.19 - $0.24
GSGTF News
GSGTF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout GenSight Biologics
Industry
Biotechnology
Sector
Health CareEmployees
12
CEO
Laurence Rodriguez
Website
www.gensight-biologics.comHeadquarters
Paris, 75012, FR
GSGTF Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-16%
Net Income Margin
-16%
Return on Equity
0%
Return on Capital
83%
Return on Assets
-2%
Earnings Yield
-74.07%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$44.61M
Shares Outstanding
234.65M
Volume
2.00K
Short Interest
0.00%
Avg. Volume
0
Financials (TTM)
Gross Profit
$1.50M
Operating Income
$15.81M
EBITDA
$11.37M
Operating Cash Flow
$12.94M
Capital Expenditure
$1.00K
Free Cash Flow
$12.94M
Cash & ST Invst.
$2.46M
Total Debt
$19.11M
GenSight Biologics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$48.00K
-96.9%
Gross Profit
$48.00K
-96.5%
Gross Margin
100.00%
N/A
Market Cap
$44.61M
N/A
Market Cap/Employee
$2.79M
N/A
Employees
16
N/A
Net Income
$6.97M
+41.8%
EBITDA
$5.86M
+48.1%
Quarterly Fundamentals
Net Cash
$18.69M
-24.5%
Accounts Receivable
$1.00K
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$5.06M
-15.7%
Short Term Debt
$13.96M
-9.3%
Return on Assets
-2.06%
N/A
Return on Invested Capital
83.20%
N/A
Free Cash Flow
$3.15M
+80.9%
Operating Cash Flow
$3.15M
+80.9%